Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage

30Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This study investigated the role of matrix metalloproteinase-9 (MMP-9) in early brain injury (EBI) after subarachnoid hemorrhage (SAH). Sprague-Dawley male rats (n=30) between 250 and 300g were used. SAH was produced by injecting autologous arterial blood into the prechiasmatic cistern. SB-3CT, a selective MMP-9 inhibitor, was injected intraperitoneally after SAH induction. MMP-9 protein expression was measured by western blot; laminin expression and neuronal cells in the cerebral cortex were studied by immunohistochemistry and TUNEL staining at 24h after SAH. MMP-9 expression was increased after SAH and decreased by SB-3CT inhibition at 24h after SAH (P < 0.01). Laminin, the substrate of MMP-9, was decreased at 24h after SAH, and SB-3CT prevented laminin degradation. The number of TUNEL-positive neurons in cerebral cortex was increased after SAH and decreased by SB-3CT (P<0.01). MMP-9 may be involved in EBI after SAH and inhibition of MMP-9 may reduce EBI in cerebral cortex. © 2011 Springer-Verlag/Wien.

Cite

CITATION STYLE

APA

Guo, Z. D., Zhang, X. D., Wu, H. T., Lin, B., Sun, X. C., & Zhang, J. H. (2011). Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage. In Acta Neurochirurgica, Supplementum (Vol. 110, pp. 81–84). Springer-Verlag Wien. https://doi.org/10.1007/978-3-7091-0353-1_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free